Innovative Chemoimmunotherapy Strategy Enhances Treatment Efficacy for Triple-Negative Breast Cancer
A study has unveiled a novel chemoimmunotherapy strategy that employs engineered tumor-derived extracellular vesicles to enhance drug delivery and improve treatment outcomes for triple-negative breast cancer (TNBC). Key Highlights Challenges…